Intensified Lipid-Lowering Therapy in Coronary Heart Disease: Is the Concept of “the Lower the Better” Evidence Based?

Invited Commentary

References and Recommended Reading

  1. 1.
    European guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 2003; 24:1601 -1610Google Scholar
  2. 2.
    Guidelines on the management of stable angina pectoris. Eur Heart J (2006) 27, 1341–1381Google Scholar
  3. 3.
    Guidelines on diabetes, pre-diabetes, and cardiovascular diseases. Eur Heart J (2007) 28, 88– 136Google Scholar
  4. 4.
    Echt, et al.: Mortality and Morbidity in Patients Receiving Encainide, Flecainide, or Placebo - The Cardiac Arrhythmia Suppression Trial. N Engl J Med 1991, 324:781–788.CrossRefPubMedGoogle Scholar
  5. 5.
    Barter P, et al.: Effects of torcetrapib in patients at high risk for coronary events. N Engl J Med 2007, 357:2109–2122.CrossRefPubMedGoogle Scholar
  6. 6.
    Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008;358:2560-2572Google Scholar
  7. 7.
    Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545-2559Google Scholar
  8. 8.
    Kastelein J, et al.: Simvastatin with or without ezetimibe in familial hypercholesterolemia. N Engl J Med 2008, 358:1431–1443.CrossRefPubMedGoogle Scholar
  9. 9.
    Villines TC, et al.: The ARBITER 6-HALTS Trial. J Am Coll Cardiol 2010, 55:2721–2726.CrossRefPubMedGoogle Scholar
  10. 10.
    Berneis K, et al.: Ezetimibe alone or in combination with simvastatin increases small dense low-density lipoproteins in healthy men: a randomized trial. Eur Heart J 2010, 31:1633–1639.CrossRefPubMedGoogle Scholar
  11. 11.
    Winkler K, et al.: Fluvastatin/fenofibrate vs. simvastatin/ezetimibe in patients with metabolic syndrome: different effects on LDL-profiles. Eur J Clin Invest 2009, 39:463–470.CrossRefPubMedGoogle Scholar
  12. 12.
    Stojakovic T, et al.: Differential effects of fluvastatin alone or in combination with ezetimibe on lipoproteinsubfractions in patients at high risk of coronary events. Eur J Clin Invest 2010, 40:187–194.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Klinik für Kardiologie, Angiologie, Pneumologie und Internistische IntensivmedizinHerzzentrum der Universität zu KölnKölnGermany

Personalised recommendations